Bacteria may be linked to lymphoma around the eye

AP is reporting on new research suggesting infection with bacteria from the Chlamydia family may play a role in the development of a type of lymphoma that affects the tissue around the eye, raising hopes that antibiotics may one day prove to be an alternative to chemotherapy or radiation.



The study, presented Monday at the European Cancer Conference, is the latest to link infection with cancer, following the establishment of the human papilloma virus as the major cause of cervical cancer and the bacteria Helicobacter pylori as a cause of stomach cancer.



The bacteria in question, Chlamydia psittaci, can be contracted from infected birds such as parrots. Scientists also suspect it can come from household cats because they also carry it. Chlamydia psittaci is known to cause a lung infection called psittacosis. The Chlamydia family of bacteria has been linked to cancer before. Scientists already have shown that another strain, Chlamydia trachomatis, is linked to the development of cervical cancer. Another, Chlamydia pneumoniae, has been linked to lung cancer.



In the future, eradication of the germ could be a common treatment method for low-grade lymphoma, replacing current cytotoxic chemotherapy or radiation.



In many of these types of lymphoma, an infection can start the process, but at some point the cancer becomes independent of the infection. So unless the infection is treated early, antibiotics may not be enough. The next step is to see whether antibiotics can reverse the cancer.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap